Latest Capital Markets Engagement News

DMC Mining Group reported a modest cash outflow for Q2 2025 while securing a loan facility variation and launching a $6 million capital raising to bolster its funding position.

Viridis Mining promotes CEO Rafael Moreno to Managing Director as the Colossus Rare Earth Project advances toward production, marking a strategic leadership shift amid key development milestones.

Fintech Chain Limited reported a 24% revenue increase to RMB55.9 million for FY2025 driven by new SaaS products, yet it remains in the red with a net loss of RMB4.8 million. The company has also applied for delisting from the ASX.

Axel REE Limited announces a strategic leadership transition as it moves from exploration to development of its rare earth and gallium projects in Brazil, appointing new technical experts and seeking a new Managing Director to guide its next growth phase.

Agrimin Limited progresses its strategic review of the Mackay Potash Project while supporting Tali Resources’ corporate restructuring and planned IPO, offering shareholders a priority investment opportunity.

Tamboran Resources reports strong progress in its Beetaloo Basin pilot project, completing key wells and securing $70 million to fund drilling and infrastructure, aiming for first gas production by mid-2026.

Tamboran Resources has finalized a US$15 million sale of 100,000 acres to Daly Waters Energy, retaining a dominant 1.9 million-acre position in the Beetaloo Basin and setting the stage for its Phase 2 gas development targeting Australia's East Coast market.

Helios Energy has confirmed significant contingent resources at its Presidio Project in West Texas, supported by new technical partnerships and a strengthened leadership team. The company raised $4.3 million to advance its development plans amid a shifting US energy landscape.

Solis Minerals appoints Mitch Thomas as CEO, shifting Mike Parker to Technical Director, ahead of a major 2025 drilling campaign in Peru's copper-rich belt.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Titomic Limited has appointed Jim Simpson as Managing Director, consolidating leadership as the company accelerates its expansion in the US additive manufacturing market.